Skip to main content
. 2023 Feb 1;62(18):2715–2724. doi: 10.2169/internalmedicine.1178-22

Figure 2.

Figure 2.

Clinical course after admission. TCZ: tocilizumab, mPSL: methylprednisolone, CsA: cyclosporin, IL-6: interleukin-6, VEGF: vascular endothelial growth factor